SMMT
Price
$18.91
Change
-$1.55 (-7.58%)
Updated
Apr 3 closing price
Capitalization
13.94B
34 days until earnings call
XERS
Price
$4.88
Change
-$0.27 (-5.24%)
Updated
Apr 3 closing price
Capitalization
751.23M
33 days until earnings call
Ad is loading...

SMMT vs XERS

Header iconSMMT vs XERS Comparison
Open Charts SMMT vs XERSBanner chart's image
Summit Therapeutics
Price$18.91
Change-$1.55 (-7.58%)
Volume$3.46M
Capitalization13.94B
Xeris Biopharma Holdings
Price$4.88
Change-$0.27 (-5.24%)
Volume$2.8M
Capitalization751.23M
SMMT vs XERS Comparison Chart
Loading...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SMMT vs. XERS commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMMT is a Hold and XERS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (SMMT: $18.91 vs. XERS: $4.88)
Brand notoriety: SMMT and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SMMT: 144% vs. XERS: 90%
Market capitalization -- SMMT: $13.94B vs. XERS: $751.23M
SMMT [@Biotechnology] is valued at $13.94B. XERS’s [@Biotechnology] market capitalization is $751.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMMT’s FA Score shows that 2 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • SMMT’s FA Score: 2 green, 3 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, SMMT is a better buy in the long-term than XERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMMT’s TA Score shows that 2 TA indicator(s) are bullish while XERS’s TA Score has 3 bullish TA indicator(s).

  • SMMT’s TA Score: 2 bullish, 6 bearish.
  • XERS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, XERS is a better buy in the short-term than SMMT.

Price Growth

SMMT (@Biotechnology) experienced а -8.20% price change this week, while XERS (@Biotechnology) price change was -13.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

SMMT is expected to report earnings on May 08, 2025.

XERS is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($13.9B) has a higher market cap than XERS($751M). XERS YTD gains are higher at: 43.953 vs. SMMT (5.968). XERS has higher annual earnings (EBITDA): -13.99M vs. SMMT (-212.51M). SMMT has more cash in the bank: 412M vs. XERS (71.6M). SMMT has less debt than XERS: SMMT (7.22M) vs XERS (271M). XERS has higher revenues than SMMT: XERS (203M) vs SMMT (0).
SMMTXERSSMMT / XERS
Capitalization13.9B751M1,851%
EBITDA-212.51M-13.99M1,519%
Gain YTD5.96843.95314%
P/E Ratio26.36N/A-
Revenue0203M-
Total Cash412M71.6M575%
Total Debt7.22M271M3%
FUNDAMENTALS RATINGS
SMMT vs XERS: Fundamental Ratings
SMMT
XERS
OUTLOOK RATING
1..100
7682
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
3160
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3535
P/E GROWTH RATING
1..100
6100
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XERS's Valuation (92) in the Pharmaceuticals Major industry is in the same range as SMMT (95) in the Biotechnology industry. This means that XERS’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (31) in the Biotechnology industry is in the same range as XERS (60) in the Pharmaceuticals Major industry. This means that SMMT’s stock grew similarly to XERS’s over the last 12 months.

SMMT's SMR Rating (98) in the Biotechnology industry is in the same range as XERS (100) in the Pharmaceuticals Major industry. This means that SMMT’s stock grew similarly to XERS’s over the last 12 months.

SMMT's Price Growth Rating (35) in the Biotechnology industry is in the same range as XERS (35) in the Pharmaceuticals Major industry. This means that SMMT’s stock grew similarly to XERS’s over the last 12 months.

SMMT's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for XERS (100) in the Pharmaceuticals Major industry. This means that SMMT’s stock grew significantly faster than XERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SMMTXERS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
MULTI.X0.0828730.007983
+10.66%
Multichain cryptocurrency
LTC.X83.3250661.566185
+1.92%
Litecoin cryptocurrency
SNX.X0.651575-0.002060
-0.32%
Synthetix cryptocurrency
BAL.X1.249141-0.007223
-0.57%
Balancer cryptocurrency
FORTH.X1.981984-0.093808
-4.52%
Ampleforth Governance Token cryptocurrency

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with TRDA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
-5.24%
TRDA - XERS
44%
Loosely correlated
-8.86%
KRYS - XERS
43%
Loosely correlated
-1.59%
SCPH - XERS
41%
Loosely correlated
-8.00%
ABOS - XERS
40%
Loosely correlated
-8.52%
FHTX - XERS
40%
Loosely correlated
-7.89%
More